July 16, 2024
Loading...
You are here:  Home  >  Health Care & Life Science  -  Page 147
Latest

Amgen subsidiary discovers rare gene that could reduce heart attack risk

By   /  Thursday, May 19th, 2016  /  Health Care & Life Science, Latest news, Technology  /  Comments Off on Amgen subsidiary discovers rare gene that could reduce heart attack risk

An Amgen subsidiary may have found a rare gene that could drastically reduce the risk of heart attacks in the future. DeCode Genetics, an Iceland-based subsidiary of Thousand Oaks biotech giant Amgen, uncovered a rare and unknown genetic variation in some people that could reduce the risk of heart attacks and lower cholesterol. The variant Read More →

Latest

Santa Barbara’s MedBridge launches surgical concierge service Kinese

By   /  Friday, May 13th, 2016  /  Health Care & Life Science, Latest news  /  Comments Off on Santa Barbara’s MedBridge launches surgical concierge service Kinese

Santa Barbara-based ambulatory surgery center developer MedBridge launched a new health care service that connects patients with surgeons. Kinese is described as a surgical concierge service that’s rolling out in Santa Barbara, Beverly Hills and San Francisco. It provides immediate access to surgeons and facilities, bypassing expensive and ambiguous costs, waitlists and limited access to Read More →

Latest

Sientra selling implants again but staff cut as losses mount

By   /  Friday, May 13th, 2016  /  Earnings, Health Care & Life Science, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Sientra selling implants again but staff cut as losses mount

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Stellar Biotechnologies revenues nearly doubled in first quarter

By   /  Monday, May 9th, 2016  /  Earnings, Health Care & Life Science, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Stellar Biotechnologies revenues nearly doubled in first quarter

Stellar Biotechnologies revenues nearly doubled but so did the company’s losses during the first quarter, the Port Hueneme biotech company reported May 9. Stellar Biotechnologies makes a protein for immunotherapy treatments using a unique sea snail only found off the coastal shores of a small part of California. The company’s revenues increased from $187,627 during Read More →

Latest

LTC Properties beat first quarter revenue estimates

By   /  Tuesday, May 3rd, 2016  /  Earnings, Health Care & Life Science, Latest news, Real Estate, Tri-County Public Companies  /  Comments Off on LTC Properties beat first quarter revenue estimates

Westlake Village-based LTC Properties beat analyst projections of revenue and funds from operations in its 2016 first quarter earnings report. The publicly traded real estate and investment trust earned $31.88 million in revenue, up from $26.68 million in the first quarter of 2015, surpassing analyst projections by $820,000. LTC Properties funds from operations per common share Read More →

Latest

UCLA Health Services buys medical office building in Thousand Oaks

By   /  Friday, April 29th, 2016  /  East Ventura County, Health Care & Life Science, Latest news, Real Estate  /  Comments Off on UCLA Health Services buys medical office building in Thousand Oaks

The UCLA Board of Regents has paid more than $10 million to buy a medical office building from TR Funding, LLC, of Westlake Village that houses UCLA Health Services at 100 Moody Court in Thousand Oaks. The 23,614-square-foot building has been home to a UCLA Health medical clinic since 2013, offering primary and specialty care Read More →

Latest

Amgen exceeds Wall Street expectations for first quarter earnings

By   /  Thursday, April 28th, 2016  /  Earnings, Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on Amgen exceeds Wall Street expectations for first quarter earnings

Amgen blew away Wall Street expectations and raised its 2016 guidance when it released first quarter earnings April 28. The Thousand Oaks biotech giant had profits of $2.2 billion, up from $1.91 billion during the same quarter last year. Revenues of $5.53 billion were also up from $5 billion in 2015 and surpassed analyst estimates Read More →